ArticleCancer reports (Hoboken, N.J.)2026

EGFR p.V774M/p. the S768I Compound Mutation in NSCLC Is a Good Prognostic Marker for IPHC- and Furmonertinib-Based Treatment: A Case Report.

Yanan Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.